Condensed Consolidated Statements of Stockholders' Equity - USD ($)		Total	Convertible Senior Notes due 2024 Convertible Debt	Warrant Issued For Vessel Consideration	[2]	Common Stock		Common Stock Convertible Senior Notes due 2024 Convertible Debt	Common Stock Warrant Issued For Vessel Consideration	[2]	Additional Paid-in Capital		Additional Paid-in Capital Convertible Senior Notes due 2024 Convertible Debt	Additional Paid-in Capital Warrant Issued For Vessel Consideration	[2]	Accumulated Deficit	Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2019	[1]					10,214,600
Beginning balance at Dec. 31, 2019		$ 481,502,937				$ 102,146	[1]				$ 918,475,145	[1]				$ (437,074,354)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(3,527,759)														(3,527,759)
Issuance of shares due to vesting of restricted shares (in shares)	[1]					62,526
Issuance of shares due to vesting of restricted shares	[1]					$ 626					(626)
Net unrealized gain/(loss) on cash flow hedges		(271,868)															(271,868)
Cash used to settle net share equity awards		(1,161,301)									(1,161,301)	[1]
Stock-based compensation		836,200									836,200	[1]
Ending balance (in shares) at Mar. 31, 2020	[1]					10,277,126
Ending balance at Mar. 31, 2020		477,378,209				$ 102,772	[1]				918,149,418	[1]				(440,602,113)	(271,868)
Beginning balance (in shares) at Dec. 31, 2019	[1]					10,214,600
Beginning balance at Dec. 31, 2019		481,502,937				$ 102,146	[1]				918,475,145	[1]				(437,074,354)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(35,178,372)
Net unrealized gain/(loss) on cash flow hedges		(1,124,745)
Ending balance (in shares) at Sep. 30, 2020	[1]					10,279,698
Ending balance at Sep. 30, 2020		446,326,450				$ 102,798	[1]				919,601,123	[1]				(472,252,726)	(1,124,745)
Beginning balance (in shares) at Mar. 31, 2020	[1]					10,277,126
Beginning balance at Mar. 31, 2020		477,378,209				$ 102,772	[1]				918,149,418	[1]				(440,602,113)	(271,868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(20,491,327)														(20,491,327)
Issuance of shares due to vesting of restricted shares (in shares)	[1]					2,572
Issuance of shares due to vesting of restricted shares	[1]					$ 26					(26)
Net unrealized gain/(loss) on cash flow hedges		(649,287)															(649,287)
Stock-based compensation		723,223									723,223	[1]
Ending balance (in shares) at Jun. 30, 2020	[1]					10,279,698
Ending balance at Jun. 30, 2020		456,960,818				$ 102,798	[1]				918,872,615	[1]				(461,093,440)	(921,155)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		(11,159,286)														(11,159,286)
Net unrealized gain/(loss) on cash flow hedges		(203,590)															(203,590)
Cash used to settle fractional shares in the Reverse Stock Split		(12,513)									(12,513)	[1]
Stock-based compensation		741,021									741,021	[1]
Ending balance (in shares) at Sep. 30, 2020	[1]					10,279,698
Ending balance at Sep. 30, 2020		446,326,450				$ 102,798	[1]				919,601,123	[1]				(472,252,726)	(1,124,745)
Beginning balance (in shares) at Dec. 31, 2020						11,661,797
Beginning balance at Dec. 31, 2020		470,418,083				$ 116,618					943,571,685					(472,137,822)	(1,132,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		9,849,310														9,849,310
Issuance of shares due to vesting of restricted shares (in shares)						71,146
Issuance of shares due to vesting of restricted shares						$ 711					(711)
Net unrealized gain/(loss) on cash flow hedges		599,884															599,884
Fees for equity offerings		(31,830)									(31,830)
Cash used to settle net share equity awards		(811,456)									(811,456)
Stock-based compensation		871,943									871,943
Ending balance (in shares) at Mar. 31, 2021						11,732,943
Ending balance at Mar. 31, 2021		480,895,934				$ 117,329					943,599,631					(462,288,512)	(532,514)
Beginning balance (in shares) at Dec. 31, 2020						11,661,797
Beginning balance at Dec. 31, 2020		470,418,083				$ 116,618					943,571,685					(472,137,822)	(1,132,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		97,415,605
Net unrealized gain/(loss) on cash flow hedges																	724,410
Ending balance (in shares) at Sep. 30, 2021						12,863,998
Ending balance at Sep. 30, 2021		607,650,746				$ 128,640					982,652,311					(374,722,217)	(407,988)
Beginning balance (in shares) at Mar. 31, 2021						11,732,943
Beginning balance at Mar. 31, 2021		480,895,934				$ 117,329					943,599,631					(462,288,512)	(532,514)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		$ 9,225,025														9,225,025
Issuance of shares due to vesting of restricted shares (in shares)						2,773
Issuance of shares due to vesting of restricted shares						$ 27					(27)
Issuance of shares upon conversion of warrants (in shares)		541,898				432,037	[2]
Issuance of shares upon conversion of warrants	[2]	$ 8,375,298				$ 4,322					8,370,976
Issuance of shares from ATM Offering, net of commissions and issuance costs (in shares)						581,385
Issuance of shares from ATM Offering, net of commissions and issuance costs		27,283,917				$ 5,814					27,278,103
Issuance of shares upon exercise of stock options (in shares)						4,117
Issuance of shares upon exercise of stock options		22,224				$ 41					22,183
Net unrealized gain/(loss) on cash flow hedges		44,320															44,320
Cash used to settle net share equity awards		(174,230)									(174,230)
Stock-based compensation		585,868									585,868
Ending balance (in shares) at Jun. 30, 2021						12,753,255
Ending balance at Jun. 30, 2021		526,258,356				$ 127,533					979,682,504					(453,063,487)	(488,194)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		78,341,270														78,341,270
Issuance of shares upon conversion of warrants (in shares)								25	109,861
Issuance of shares upon conversion of warrants			$ 982	$ 2,304,690					$ 1,099				$ 982	$ 2,303,591
Issuance of shares upon exercise of stock options (in shares)						857
Issuance of shares upon exercise of stock options		33,354				$ 8					33,346
Net unrealized gain/(loss) on cash flow hedges		80,206															80,206
Issuance costs for ATM Offering		(145,580)									(145,580)
Stock-based compensation		777,468									777,468
Ending balance (in shares) at Sep. 30, 2021						12,863,998
Ending balance at Sep. 30, 2021		$ 607,650,746				$ 128,640					$ 982,652,311					$ (374,722,217)	$ (407,988)

[1] Adjusted to give effect for the 1-for-7 reverse stock split that became effective as of September 15, 2020.

[2] Please see Note 3 Vessels for additional information.